CALGB 9251 Report for Patients Like You

Filter by:

All
Start typing to see suggestions

patients

Home > Community Treatment Reports and Side Effects > CALGB 9251 Treatment Report

You appear to have JavaScript disabled in your browser. PatientsLikeMe relies on JavaScript and Cookies to deliver the best possible experience to you. How do I enable JavaScript?

What is CALGB 9251?

CALGB 9251 is a chemotherapy regimen that includes cyclophosphamide and prednisone followed by ifosfamide or cyclophosphamide; high dose methotrexate, leucovorin, vincristine, dexamethasone and either doxorubicin or etoposide or cytarabine or intrathecal methotrexate, cytarabine and hydrocortisone.

0 patients have reported taking CALGB 9251 .

Report created on May 26, 2012.